Hemangiosarcoma in Horses: Rare Blood Vessel Cancer

Hemangiosarcoma is a malignant cancer of endothelial cells, the cells that line blood vessels. In horses, it is uncommon, but when it does occur it can be serious because these tumors are fragile, blood-filled, and prone to bleeding. That means a horse may look only mildly unwell at first, then become much sicker if a mass ruptures or if the cancer has already spread.

Published case reviews in horses describe hemangiosarcoma most often in mature, especially middle-aged, horses. The lungs and pleura, skeletal muscle, and spleen have been reported as common sites in disseminated disease, although tumors can also involve skin and other organs. Because this cancer can spread through the bloodstream, some horses have multiple affected areas by the time the problem is recognized.

For pet parents, one of the hardest parts is that signs may be nonspecific. A horse may seem tired, breathe harder than usual, lose condition, or develop unexplained swelling. In other cases, the first obvious problem is a nosebleed, lameness, or sudden weakness related to internal hemorrhage. Your vet can help sort out whether these signs fit cancer, trauma, infection, or another condition with similar symptoms.

In most horses, the exact cause is unknown. Hemangiosarcoma develops when endothelial cells become cancerous and start forming abnormal blood-filled channels. Like many cancers, it is probably multifactorial, meaning genetics, age, environment, and random cellular changes may all play a role.

Equine case reports do not point to one clear trigger. Hemangiosarcoma has been described more often in mature horses, and one older review found Thoroughbreds appeared overrepresented, although a true breed predisposition was not proven. That means breed may be a possible pattern in reported cases, not a confirmed risk factor.

For cutaneous or dermal hemangiosarcoma in animals, chronic solar irritation is considered a possible contributor in some cases. That connection is better described for skin forms than for internal tumors, so it should not be assumed to explain every horse with this cancer. Your vet may also discuss whether a mass seems primary or whether it may represent spread from another site.

Diagnosis usually starts with a full physical exam and basic testing. Your vet may recommend a CBC and chemistry panel to look for anemia, inflammation, platelet changes, and organ effects. In published equine cases, anemia was common, and some horses also had neutrophilic leukocytosis and thrombocytopenia.

From there, imaging helps your vet look for bleeding, fluid, or masses. Depending on the signs, that may include thoracic ultrasound, abdominal ultrasound, radiographs, or referral imaging. If there is fluid in the chest, abdomen, or around another structure, fluid analysis may help characterize bleeding or inflammation, although it does not always give a definitive cancer diagnosis.

A tissue sample is the most important step for confirmation. Fine-needle aspirate, biopsy, or surgical removal of a mass may allow histopathology to identify hemangiosarcoma. Still, this cancer can be frustrating to diagnose before death because lesions may be deep, fragile, or widespread. In one classic equine case series, only a small number of horses were diagnosed antemortem by aspirate or biopsy, while most were confirmed on postmortem examination.

If a horse dies or is euthanized before a diagnosis is reached, necropsy can provide valuable answers for the care team and pet parent. It can confirm the tumor type, show how far disease had spread, and sometimes guide decisions for related horses if environmental concerns are being considered.

There is no proven way to prevent hemangiosarcoma in horses. Because the exact cause is usually unknown, prevention focuses more on early detection and general skin and health management than on a guaranteed strategy.

Routine exams matter. Ask your vet to evaluate unexplained swellings, persistent skin masses, recurrent nosebleeds, unexplained anemia, or changes in breathing and stamina. Catching a localized lesion earlier may create more options, even though many internal tumors remain hard to detect before they cause signs.

For horses with lightly pigmented skin or frequent sun exposure, practical sun protection may be worth discussing with your vet, especially if there are suspicious skin lesions. While solar irritation has been linked more clearly to dermal hemangiosarcoma in animals than to internal disease, reducing chronic sun damage is still a sensible part of skin care.

Most importantly, focus on prompt evaluation rather than self-diagnosis. Hemangiosarcoma is rare, and many more common conditions can mimic it. Your vet can help decide whether a lump, swelling, or bleeding episode needs monitoring, biopsy, referral, or urgent intervention.